Memorandum of understanding between "State Institute of Drugs and Good Practices" of Russia and AEMPS

Last update: 5/3/2019

PDF version

MEMORANDUM OF UNDERSTANDING BETWEEN “STATE INSTITUTE OF DRUGS AND GOOD PRACTICES” OF RUSSIA AND AEMPS

Publication date: 5 March 2019

Category: AEMPS
Reference: AEMPS, 6_vi /2019

On the 5th of March a cooperation agreement in terms of Good Manufacturing Practice as well as collaboration in sharing strategies to fight against falsified medicines has been signed between the Federal State Institution “State Institute of Drugs and Good Practices” from the Federation of Russia and the Spanish Agency of Medicines and Medical Devices.

This agreement contributes to reinforce the exchange of information and experiences among both inspection services in order to facilitate the convergence in these activities.

The Director of the Federal State Institution “State Institute of Drugs and Good Practices” from the Federation of Russia (FSI “SID & GP”), Mr. Vladislav Shestakov, and the Director of the AEMPS, Ms. María Jesús Lamas, have signed a cooperation agreement in terms of good manufacturing practice inspections as well as collaboration in the exchange of strategies to fight against falsified medicines.

The Memorandum of Understanding will come into force on the 6th of March once both counterparts have signed.

Purpose of the Memorandum of Understanding

The mission of the AEMPS is to ensure quality, safe, effective and accessible medicines and medical devices to citizens likewise to provide them with accurate related information.

In the framework of a growing globalization of the manufacturing of medicines and active substances is of great interest, for the efficient development of AEMPS mission, to arrange mechanisms for the exchange of information and cooperation with authorities of other countries with similar roles.

Hence, through this agreement, both institutions will strengthen the activities of exchange of information and experiences among the pharmaceutical inspection services to foster and harmonize criteria in order to impact in the quality of these activities.

Furthermore, falsified and illegal medicines and medical devices, spread out worldwide, imply an important risk for public health. The manufacturing, distribution and sale of these products are an awfully lucrative and illegal business which entails a global threat for patients’ health. Thus, by virtue of this agreement, the FSI “SID & GP” and the AEMPS will additionally collaborate by sharing strategies in this area what will certainly strengthen the effectiveness of these actions for both institutions to safeguard citizens’ health.

If you want to find any information related to this website, please use the search application on the top of the page